About Lupin8


  1. Lupins for Food & Health. Dr Mark Sweetingham, Dept of Agriculture, Govt of Western Australia
  2. Knauf U, Seger A, Bagger C and Bez J, 2007, Lupin food ingredients and lupin-based food products.
  3. Johnson S, Chua V, Hall R and Baxter, A, 2006, Lupin kernel fibre foods improve bowel function and beneficially modify some putative faecal risk factors for colon cancer in men. The British Journal of Nutrition: an international journal of nutritional science, Vol95,pp. 372-378, Canbridge university Press, United Kindom.
  4. Chiesa G, Johnson S, Marchesi M, Parolini C, Caligari S, Gillo D, Cornelli L, Diani E, Rigamnti E and Sitori C, 2006, Lupin Protein: A new souce of cardiovascular protective agents, XIV International Symposium on Athersclerosis, Elsevier Ireland Ltd, Ireland.
  5. Smith, S., Choy, R., Johnson, S., Hall, R., Wildeboer-Veloo, A.* and Welling, G.* (2006) Lupin kernel fiber consumption modifies fecal microbiota in healthy men as determined by rRNA gene flourescent in situ by hybridization., European Journal of Nutrition, Vol 45, pp. 335-341, Dr. Dietrich Steinkopff Verlag, Gernany
  6. Hall, R., Johnson, S., Baxter, A. and Ball, M. (2005) Lupin kernel fibre-enriched foods beneficially modify serum lipids in men, European Journal of Clinical Nutrition, Vol 59, 2005, pp. 325-333, Nature Publishing Group, United Kingdom, Switzerland
  7. Hall, R., Thomas, S. and Johnson, S. (2005) Australian sweet lupin flour addition reduces the glycaemic index of a white bread breakfast without affecting palatability in healthy human volunteers, Asia Pacific Journal of Clinical Nutrition, Vol 14, No 1, pp. 91-97, HEC Press, Australia
  8. Johnson, S., Hall, R. and Smith, S. (2005) Australian Sweet Lupin Kernel Fibre: Current Evidence of Health Benefits, Healthy ProFood, Optimised processes for preparing healthy and added value food ingredients from lipin kernels, the european protein-rich grain legume, Proceedings of the Final conference of the European project, Aracne, Italy
  9. Archer, B., Johnson, S., Devereux, H. and Baxter, A. (2004) Effect of fat replacement by insulin or lupin-kernal fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men, The British Journal of Nutrition: an international journal of nutritional science, 2004 No 91, pp. 591-599, CABI Publishing, United Kingdom
  10. Johnson, S., McQuillan, P., Sin, J. and Ball, M.* (2003) Sensory acceptability of white bread with added Australian sweet lupin (Lupinus angustifolius) kernel fibre and its glycaemic and insulinaemic responses when eaten as a breakfast, Journal of the Science of Food and Agriculture, Vol 83, No 13, pp. 1366-1372, John Wiley & Sons Ltd, United Kingdom
  11. Adams PB, Lawson S, Sanigorski A and Sinclair A, 1996, Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression, Lipids 31(Suppl):157-61.
  12. Carpenter YA, Portois L, Malaisse WJ, 2006, n-3 Fatty acids and the metabolic syndrome, American Journal of Clinical Nutrition 83 (suppl): 1499S-504S.
  13. De Lorgeril M, Renaud S, Mamelle N, et al, 1994, Alpha-linolenic rich Mediterranean diet in secondary prevention of coronary heart disease, Lancet 343: 1454-59.
  14. De Logerill, M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N, 1999, Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascualar Complications After Myocardial Infarction. Final report of the Lyon Diet Heart Study, Circulation 99:779-85.
  15. Dolocek TA, 1992, Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial, Society for Experimental Biology and Medicine 200:177-82.
  16. Gebauer SK , Psota TL, Harris WS, Kris-Etherton PM, 2006, n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits, American Journal of Clinical Nutrition 83(suppl):1526S-35S.
  17. Geusens P, Wouters C, Nijs J, Jiang Y and Dequeker J, 1994, Long term Effect of Omega-3 Fatty Acids Supplementation in Active Rheumatoid Arthritis, Arthritis and Rheumatism 37:824-29.
  18. GISSI-Prevenzione Investigators, 1999, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial, Lancet 354:447-55.
  19. Jensen CL, 2006, Effects of n-3 fatty acids during pregnancy and lactation, American Journal of Clinical Nutrition 83 (suppl): 1452S-7S.
  20. Johnson EJ, Schaefer EJ, 2006, Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration, American Journal of Clinical Nutrition 83 (Suppl):1494S-8S.
  21. Keys A, Menotti A, Karvonen MJ, Aravanis C, Balckburn H, Buzina R et al, 1986, The Diet and 15-year death rate in the seven countries study, American Journal of Epidemiology 124(6):903-15.
  22. Leaf A, Kang JX, Xiao YF, Billman GE, 2003, Special Review, Clinical Prevention of Sudden Cardiac Death by n-3 Polynsaturated Fatty Acids and Mechanism of Arrhythmias by n-3 Fish Oils, Circulation 107: 2646-64.
  23. National Health & Medical Research Council (NHMRC), 2006, Nutrient Reference Values for Australia and New Zealand . Commonwealth of Australia.
  24. National Heart Foundation of Australia, 2001, Cardiovascular Disease – Australia’s Major Health Problem . Available at: . Accessed 14 December 2006.
  25. Parker G, Gibson NA, Brotchie H, Heruc G, Rees A, Hadzi-Pavlovic D, 2006, Omega-3 fatty acids and Mood Disorders. The American Journal of Psychiatry 163 (6): 969-78.
  26. Purba M, Kouris-Blazos A, Wattanapenpaiboon N, Lukito W, Rothenberg EM, Steen BC and Wahlqvist ML, 2001, Skin Wrinkling: Can Food Make a Difference? Journal of the American College of Nutrition 20:(1): 71-80.
  27. Ratnesar S, 2002, The Omega-3 Life Program: Your Food Guide for Health and Healing, McGraw-Hill Australia , Sydney .
  28. Ratnesar S, 2006, The Omega-3 Diet Revolution: The Ultimate Health & Weight Loss Solution, Pan Macmillan Australia , Sydney .
  29. Richardson AJ and Montgomery P, 2005, The Oxford-Durham study: a randomised controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder, Pediatrics 115 (5): 1360-6.
  30. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fara S, Robins SJ, Au R et al, 2006, Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease, Archives of Neurology 63: 1545-50.
  31. Stevens LJ, Zentall SS, Abate ML, Kuczek T and Burgess JR, 1996, Omega-3 Fatty Acids in Boys with Behaviour, Learning and Health Problems, Physiology and Behaviour 59(4):915-20.
  32. Torjesen P.A. Birkeland K.I. Anderssen S.A. Hjermann I. Holme I, Urdal P, 1997, Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome, Diabetes Care : 20(1):26-31.

Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M, 1998, Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 moths of age, Lancet 352: 688-91.



  1. Herbert V. Folic Acid. In: Shils M, Olson J, Shike M, Ross AC, ed. Nutrition in Health and Disease. Baltimore: Williams & Wilkins, 1999.
  2. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997;24:S18-30-S18-39. [PubMed abstract]
  3. Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998;19:1163-71. [PubMed abstract]
  4. Zittoun J. Anemias due to disorder of folate, vitamin B12 and transcobalamin metabolism. Rev Prat 1993;43:1358-63. [PubMed abstract]
  5. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press. Washington, DC, 1998.
  6. McNulty H. Folate requirements for health in different population groups. Br J Biomed Sci 1995;52:110-9. [PubMed abstract]
  7. Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP, Cardoso JN, Leitao CN, Mira FC. Hyperhomocysteinemia in chronic alcoholism: Correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 1996;63:220-4. [PubMed abstract]
  8. Pietrzik KF and Thorand B. Folate economy in pregnancy. Nutrition 1997;13:975-7. [PubMed abstract]
  9. Kelly GS. Folates: Supplemental forms and therapeutic applications. Altern Med Rev 1998;3:208-20. [PubMed abstract]
  10. Haslam N and Probert CS. An audit of the investigation and treatment of folic acid deficiency. J R Soc Med 1998;91:72-3. [PubMed abstract]
  11. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-26. [PubMed abstract]
  12. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. J Am Med Assoc 1988;260:3141-5. [PubMed abstract]
  13. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. J Am Med Assoc 1989;262:2847-52. [PubMed abstract]
  14. MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LC. Impact of folic acid fortification on the US food supply on the occurrence of neural tube defects. J Am Med Assoc 2001;285:2981-6.
  15. Gloria L, Cravo M, Camilo ME, Resende M, Cardoso JN, Oliveira AG, Leitao CN, Mira FC. Nutritional deficiencies in chronic alcoholics: Relation to dietary intake and alcohol consumption. Am J Gastroenterol 1997;92:485-9. [PubMed abstract]
  16. Collins CS, Bailey LB, Hillier S, Cerda JJ, Wilder BJ. Red blood cell uptake of supplemental folate in patients on anticonvulsant drug therapy. Am J Clin Nutr 1988;48:1445-50. [PubMed abstract]
  17. Young SN and Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiat 1989;13:841-63. [PubMed abstract]
  18. Munoz-Garcia D, Del Ser T, Bermejo F, Portera A. Truncal ataxia in chronic anticonvulsant treatment. Association with drug-induced folate deficiency. J Neurol Sci 1982;55:305-11. [PubMed abstract]
  19. Eller DP, Patterson CA, Webb GW. Maternal and fetal implications of anticonvulsive therapy during pregnancy. Obstet Gynecol Clin North Am 1997;24:523-34. [PubMed abstract]
  20. Baggott JE, Morgan SL, HaT, Vaughn WH, Hine RJ. Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem 1992;282:197-202. [PubMed abstract]



  1. Anon: Drug Facts and Comparisons. Facts and Comparisons Inc, St Louis, MO; 1999.
  2. Cohen L & Morgan J: Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol. J Fam Pract 1988; 26:145-150.
  3. Taketomo CK, Hodding JH & Kraus DM: Pediatric Dosage Handbook, 5th ed. Lexicomp, Hudson, Ohio; 1998:783.
  4. Darras BT, Ampola MG, Dietz WH et al: Intermittent dystonia in Hartnup disease. Pediatr Neurol 1989; 5:118-120.
  5. Rockwell KA: Potential interaction between niacin and transdermal nicotine (letter). Ann Pharmacother 1993;27:1283-1284.
  6. Patterson DJ, Dew EW, Gyorkey F et al: Niacin hepatitis. South Med J 1983; 76:240-241.
  7. Crouse JR III: New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug. Coronary Artery Disease 1996; 7:321-326.
  8. Schwab RA & Bachhuber BH: Delirium and lactic acidosis caused by ethanol and niacin co-ingestion. Am J Emerg Med 1991; 9:363-365.
  9. Figge HL, Figge J, Souney PF et al: Nicotinic acid: a review of its clinical use in the treatment of lipid disorders. Pharmacotherapy 1988; 8:287-294.
  10. Donowitz M, Wicks J & Sharp GW: Drug therapy for diarrheal diseases: a look ahead. Rev Infect Dis 1986; 8 (suppl 2): S18-S20.
  11. Jonas WB, Rapoza CP & Blair WF: The effect of niacinamide on osteoarthritis: a pilot study. Inflamm Res 1996; 45(7): 330-334.
  12. Pasternak RC, Brown LE, Stone PH et al: Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and “normal” cholesterol levels: a randomized, placebo-controlled trial: Harvard Atherosclerosis Reversibility Project (HARP) study group. Ann Intern Med 1996; 125(7): 529-540
  13. Ding RW, Kolbe K, Merz B et al: Pharmacokinetics of nicotinic acid-salicylic acid interaction. Clin Pharmacol Ther 19889; 46(6): 642-647.
  14. Anon: Lipid-lowering drugs. Med Lett Drugs Ther 1985; 27(695): 74-76.

Anon: Chaparral-induced toxic hepatitis – California and Texas, 1992. MMWR 1992; 41(43):812-814.



  1. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-91.
  2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effects of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
  3. Omenn GS, Goodman G, Thomquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994;54(7 Suppl):2038s-43s.
  4. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
  5. Lee IM, Cook NR, Manson JE. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: Women’s Health Study. J Natl Cancer Inst 1999;91:2102-6.
  6. American Dietetic Association: Nutrition and you: Trends 2002. Available online at Accessed January 16, 2007.
  7. Krumm S: Tasty cranberries add antioxidants to diet. Lawrence Journal-World, December20 , 2006.
  8. Schmeltzer J: Wrigley takes dip in chocolate. Chicago Tribune, December 16, 2006.
  9. Reuters Health: Nutrients may help older people fight flu. Available online at today. Accessed January 16, 2007.
  10. International Food Information Council: Functional foods fact sheet: Antioxidants. Available online at Accessed January 16, 2007.
  11. Lichtenstein AH, Russell RM: Essential nutrients: Food or supplements? JAMA 294:351–358, 2005.[Abstract/Free Full Text]
  12. American Diabetes Association: Nutrition recommendations and interventions for diabetes—2006 (Position Statement). Diabetes Care 29:2140–2157, 2006.[Free Full Text]
  13. Lichtenstein AH, Appel LJ, Brands M, et al.: Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82–96, 2006.



  1. Sandstead HH. Understanding zinc: Recent observations and interpretations. J Lab Clin Med 1994;124:322-327.
  2. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press. Washington, DC, 2001.
  3. Solomons NW. Mild human zinc deficiency produces an imbalance between cell-mediated and humoral immunity. Nutr Rev 1998;56:27-28.
  4. Prasad AS. Zinc: An overview. Nutrition 1995;11:93-99.
  5. Heyneman CA. Zinc deficiency and taste disorders. Ann Pharmacother 1996;30:186-187.
  6. Prasad AS, Beck FW, Grabowski SM, Kaplan J, Mathog RH. Zinc deficiency: Changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects. Proc Assoc Am Physicians 1997;109:68-77.
  7. Simmer K and Thompson RP. Zinc in the fetus and newborn. Acta Paediatr Scand Suppl 1985;319:158-163.
  8. Fabris N and Mocchegiani E. Zinc, human diseases and aging. Aging (Milano) 1995;7:77-93.
  9. U.S. Department of Agriculture, Agricultural Research Service. 2001. USDA Nutrient Database for Standard Reference, Release 14. Nutrient Data Laboratory Home Page, Search the database online.
  10. Sandstrom B. Bioavailability of zinc. Eur J Clin Nutr 1997;51 Suppl 1:S17-S19.
  11. Wise A. Phytate and zinc bioavailability. Int J Food Sci Nutr 1995;46:53-63.
  12. Alaimo K, McDowell MA, Briefel RR, Bischlf AM, Caughman CR, Loria CM, Johnson CL. Dietary Intake of Vitamins, Minerals, and Fiber of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. In: Johnson GV, ed. Hyattsville, MD: Vital and Health Statistics of the Center for Disease Control and Prevention/National Center for Health Statistics, 1994:1-28.
  13. Interagency Board for Nutrition Monitoring and Related Research. Third Report on Nutrition Monitoring in the United States. Washington, DC: U.S. Government Printing Office, 1995.
  14. Prasad AS. Zinc deficiency in women, infants and children. J Am Coll Nutr 1996;15:113-120.
  15. Hambidge KM, Mild zinc deficiency in human subjects. In: Mills CF, ed. Zinc in Human Biology, New York: Springer-Verlag 1989 Pp 281-296.
  16. King JC and Keen CL. Zinc. In: Modern Nutrition in Health and Disease, 9th ed. Shils ME, Olson JA, Shike M, Ross AC, eds. Baltimore: Williams & Wilkins, 1999, Pp223-239.
  17. Krasovec M and Frenk E. Acrodermatitis enteropathica secondary to Crohn’s disease. Dermatology 1996;193:361-363.
  18. Ploysangam A, Falciglia GA, Brehm BJ. Effect of marginal zinc deficiency on human growth and development. J Trop Pediatr 1997;43:192-198.
  19. Nishi Y. Zinc and growth. J Am Coll Nutr 1996;15:340-344.
  20. Van Wouwe JP. Clinical and laboratory assessment of zinc deficiency in Dutch children. A review. Biol Trace Elem Res 1995;49:211-225.
  21. Gibson RS. Content and bioavailability of trace elements in vegetarian diets. Am J Clin Nutr 1994;59:1223S-1232S.
  22. Brown KH, Allen LH, Peerson J. Zinc supplementation and children’s growth: A meta-analysis of intervention trials. Bibl Nutr Dieta 1998;54:73-76.
  23. Krebs NF. Zinc supplementation during lactation. Am J Clin Nutr 1998;68 (2 Suppl):509S – 512S.
  24. Menzano E and Carlen PL. Zinc deficiency and corticosteroids in the pathogenesis of alcoholic brain dysfunction–a review. Alcohol Clin Exp Res 1994;18:895-901.
  25. Navarro S, Valderrama R, To-Figueras J, Gimenez A, Lopez JM, Campo E, Fernandez-Cruz L, Rose E, Caballeria J, Pares A. Role of zinc in the process of pancreatic fibrosis in chronic alcoholic pancreatitis. Pancreas 1994;9:270-274.
  26. Naber TH, van den Hamer CJ, Baadenhuysen H, Jansen JB. The value of methods to determine zinc deficiency in patients with Crohn’s disease. Scand J Gastroenterol 1998;33:514-523.
  27. Shankar AH and Prasad AS. Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S-463S.
  28. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997;272:E1002-1007.
  29. Black RE. Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries. Am J Clin Nutr 1998;68:476S-479S.
  30. Anderson I. Zinc as an aid to healing. Nurs Times 1995;91:68, 70.
  31. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the common cold. Ann Pharmacother 1998;32:63-69.
  32. Turner RB and Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis 2000;31:1202-1208.
  33. Whittaker P. Iron and zinc interactions in humans. Am J Clin Nutr 1998;68:442S-446S.
  34. Hooper PL, Visconti L, Garry PJ, Johnson GE. Zinc lowers high-density lipoprotein-cholesterol levels. J Am Med Assoc 1980;244:1960-1961.
  35. Lewis MR and Kokan L. Zinc gluconate: Acute ingestion. J Toxicol Clin Toxicol 1998;36:99-101. 3
  36. Dietary Guidelines Advisory Committee, Agricultural Research Service, United States Department of Agriculture (USDA). HG Bulletin No. 232, 2000.
  37. Center for Nutrition Policy and Promotion, United Stated Department of Agriculture. Food Guide Pyramid, 1992 (slightly revised 1996).



  1. Alappan R, Perazella MA, Buller GK, et al. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med. 1996;124(3):316-320.
  2. Appel LJ. Nonpharmacologic therapies that reduce blood pressure: a fresh perspective. Clin Cardiol . 1999;22(Suppl. III):III1-III5.
  3. Apstein C. Glucose-Insulin-Potassium for acute myocardial infraction: remarkable results from a new prospective, randomized trial. Circ . 1998;98:2223–2226.
  4. Apstein CS, Opie Lh. Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther . 1999;13(3):185-189.
  5. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among U.S. men. Circ . 1998;98:1198–1204.
  6. Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. Arch Intern Med. 1996;156:61–72.
  7. Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med . 1999;107(6A):65S-70S.
  8. Burgess E, Lewanczuk R, Bolli P, et al. Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ . 1999;160(9 Suppl):S35-S45.
  9. Cappuccio EP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens . 1991;9:465-473.
  10. Chiu TF, Bullard MJ, Chen JC, Liaw SJ, Ng CJ. Rapid life-threatening hyperkalemia after addition of amiloride HCL/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy. Ann Emerg Med . 1997;30(5):612-615.
  11. Gilliland FD, Berhane KT, Li YF, Kim DH, Margolis HG. Dietary magnesium, potassium, sodium, and children’s lung funtion. Am J Epidemiol. 2002. 15;155(2):125-131.
  12. Hermansen K. Diet, blood pressure and hypertension . Br J Nutr . 2000:83(Suppl 1):S113-119.
  13. Heyka R. Lifestyle management and prevention of hypertension. In: Rippe J, ed. Lifestyle Medicine . 1st ed. Malden, Mass: Blackwell Science; 1999:109-119.
  14. Hijazi N, Abalkhail B, Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax . 2000;55:775-779.
  15. Howes LG. Which drugs affect potassium? Drug Saf . 1995;12(4):240-244.
  16. Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke . 1999;30(9):1772-1779.
  17. Joint National Committee. Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med. 1997;157:2413-2446.
  18. Kendler BS. Recent nutritional approaches to the prevention and therapy of cardiovascular disease. Prog Cardiovasc Nurs . 1997;12(3):3-23.
  19. Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines. Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation . 2000;102:2284-2299.
  20. Matsumura M, Nakashima A, Tofuku Y. Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. Intern Med . 2000;39(1):55-57.
  21. Newnham DM. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Saf . 2001;24(14):1065-1080.
  22. Olukoga A, Donaldson D. Liquorice and its health implications. J Royal Soc Health . 2000;120(2):83-89.
  23. Pasic S, Flannagan L, Cant AJ. Liposomal amphotericin is safe in bone marrow transplantation for primary immunodeficiency. Bone Marrow Transplant. 1997;19(12):1229-1232.
  24. Perazella MA. Trimethoprim-induced hyperkalemia: clinical data, mechanism, prevention and management. Drug Saf. 2000;22(3):227-236.
  25. Perazella M, Mahnensmith R. Hyperkalemia in the elderly. J Gen Intern Med. 1997;12:646–656.
  26. Physicians’ Desk Reference . 55th ed. Montvale, NJ: Medical Economics Co., Inc.; 2001:1418-1422, 2199-2207.
  27. Poirier TI. Reversible renal failure associated with ibuprofen: case report and review of the literature. Drug Intel Clin Pharm . 1984;18(1):27-32.
  28. Preston RA, Hirsh MJ MD, Oster, JR MD, et al. University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia. Am J Ther . 1998; 5(2):125-132.
  29. Ray K, Dorman S, Watson R. Severe hyperkalemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction. J Hum Hypertens . 1999;13(10):717-720.
  30. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut . 1997;40:754-760.
  31. Sacks FM, Willett WC, Smith A, et al. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertens . 1998;31(1):131–138.
  32. Shionoiri H. Pharmacokinetic drug interactions with ACE inhibitors. Clin Pharmacokinet. 1993;25(1):20-58.
  33. Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction. Int J Clin Pharmacol Thera . 1996;34:219–225.
  34. Stanbury RM, Graham EM. Systemic corticosteroid therapy – side effects and their management. Br J Ophthalmol . 1998;82(6):704-708.
  35. Suter PM. Potassium and Hypertension. Nutrition Reviews . 1998;56:151–133.
  36. Tucker KL, Hannan Mt, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr . 1999;69(4):727-736.
  37. Whang R, Oei TO, Watanabe A. Frequency of hypomagnesia in hospitalized patients receiving digitalis. Arch Intern Med . 1985;145(4):655-656.
  38. Whelton, A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Ann Intern Med . 1990;112(8):568-576.
  39. Young DB, Lin H, McCabe RD. Potassium’s cardiovascular protective mechanisms. Am J Physiology . 1995;268(part 2):R825–R837.

Vitamin E


  1. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328(20):1450-1456. (PubMed)
  2. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328(20):1444-1449. (PubMed)
  3. Willett W. Personal Communication, 2000.
  4. Schwenke D.C. Does lack of tocopherols and tocotriemols put women at increased risk of breast cancer? Journal of Nutritional Biochemistry 13 (2002) 2-20.
  5. Institute of Medicine, Food and Nutrition board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC, 2000.
  6. Weitberg AB and Corvese D. Effect of vitamin E and beta-carotene on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. J Exp Clin Cancer Res 1997;16:11-4.
  7. Freudenheim J.L., et al. Premenopausal breast cancer risk and intake of vegetables, fruits and related nutrients. J. Natl. Cancer Inst. 88 (1996) 340-348.
  8. Zhong S., et al. Dietary crotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 91 (1999) 547-556.
  9. Shibata A., et al. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly-a prospective study. Br. J. Cancer. 66 (1992) 673-679.
  10. Nesaretnam, K. et al. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469.
  11. Lonn EM and Yusuf S. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data. Can J Cardiol 1997;13:957-65.
  12. Nesaretnam K., et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143.
  13. Sigournas G., et al. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer 28 (1997) 30-35.
  14. Yu W, et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 (1999) 26-32.
  15. McIntyre B.S., et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Exp. Biol. Med. 224 (2000) 292-301.
  16. Leske MC, Chylack LT Jr., He Q, Wu SY, Schoenfeld E, Friend J, Wolfe J. Antioxidant vitamins and nuclear opacities: The longitudinal study of cataract. Ophthalmology 1998;105:831-6.
  17. Chan JM, Stampfer MJ, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 1998;8:263-73.
  18. Kappus H and Diplock AT. Tolerance and safety of vitamin E: A toxicological position report. Free Radic Biol Med 1992;13:55-74.
  19. Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R, Schaefer EJ. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr 1998;68:311-8.

Dietary Fibre


  1. Truswell AS. Cereal grains and coronary heart disease. A review of the literature commissioned by “Go Grains” in 1999 (
  2. National Food Authority. Code of Practice. Nutrient claims in food labels and in advertisements. Canberra: AGPS; 1995.
  3. The Australian Guide to Healthy Eating. Background information for nutrition educators. Canberra: Commonwealth of Australia; 1998.
  4. Definition and analysis of dietary fibre in the context of food carbohydrates N-G Asp
  5. Whole grain health claims in the United States, United Kingdom and Sweden Len Marquart, Nils-Georg Asp and David P Richardson
  6. The importance of food structure on the Glycemic responses of carbohydrate rich foods Charles S Brennan, Victor Kuri and Carmen M Tudorica
  7. Dietary Fibre Intake, Disease Prevention, and Health Promotion: An overview with emphasis on evidence from epidemiology Julie Miller Jones
  8. Experimental studies of dietary fibre and colon cancer- an overview Graeme H McIntosh
  9. Effects of resistant maltodextrin on metabolism of glucose and lipids Kazuhiro Okuma and Yuka Kishimoto

Effect of extracellular polysaccharides on satiety WAM Blom, HFJ Hendriks, A Stafleu, C de Graaf, FJ Kok and G Schaafsma